• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期肝细胞癌和发育异常结节。

Early hepatocellular carcinoma and dysplastic nodules.

作者信息

Kojiro Masamichi, Roskams Tania

机构信息

Department of Pathology, Kurume University School of Medicine, Kurume-shi 830-0011, Japan.

出版信息

Semin Liver Dis. 2005;25(2):133-42. doi: 10.1055/s-2005-871193.

DOI:10.1055/s-2005-871193
PMID:15918142
Abstract

It has been established that small, equivocal nodular lesions such as dysplastic nodules (DNs) and small well-differentiated hepatocellular carcinomas (early HCCs) are frequently observed in noncancerous liver tissues resected along with HCCs and in explant cirrhotic livers. DNs are classified into low-grade DNs or high-grade DNs on the basis of cytological and architectural atypia; high-grade DNs show varying degrees of cytological or architectural atypia, or both. Early HCCs are indistinctly nodular and highly differentiated and are frequently difficult to differentiate from high-grade DNs. Although the pathological diagnosis of high-grade DNs and early HCCs is controversial, the presence of tumor cell invasion into the intratumoral portal tracts (stromal invasion) is a helpful clue for differentiating early HCC from high-grade DNs. It is highly suggested that many HCCs occurring in cirrhotic liver arise in DNs and develop to classical HCC in a multistep fashion.

摘要

已经确定,在与肝细胞癌(HCC)一起切除的非癌性肝组织以及移植的肝硬化肝脏中,经常观察到小的、不明确的结节性病变,如发育异常结节(DNs)和小的高分化肝细胞癌(早期HCC)。DNs根据细胞学和结构异型性分为低级别DNs或高级别DNs;高级别DNs表现出不同程度的细胞学或结构异型性,或两者皆有。早期HCC结节不明显且分化程度高,常常难以与高级别DNs区分开来。尽管高级别DNs和早期HCC的病理诊断存在争议,但肿瘤细胞侵入瘤内门静脉分支(间质浸润)的存在是区分早期HCC和高级别DNs的有用线索。强烈提示,许多发生在肝硬化肝脏中的HCC起源于DNs,并以多步骤方式发展为典型的HCC。

相似文献

1
Early hepatocellular carcinoma and dysplastic nodules.早期肝细胞癌和发育异常结节。
Semin Liver Dis. 2005;25(2):133-42. doi: 10.1055/s-2005-871193.
2
Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.小胆管反应有助于界定早期间质浸润、小肝细胞癌和发育异常结节。
Cancer. 2007 Mar 1;109(5):915-23. doi: 10.1002/cncr.22460.
3
Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view.聚焦发育异常结节与早期肝细胞癌:东方视角
Liver Transpl. 2004 Feb;10(2 Suppl 1):S3-8. doi: 10.1002/lt.20042.
4
Expression of DNA methyltransferases in multistep hepatocarcinogenesis.DNA甲基转移酶在多步骤肝癌发生过程中的表达
Hum Pathol. 2003 Jan;34(1):11-7. doi: 10.1053/hupa.2003.5.
5
Pathological diagnosis at early stage: reaching international consensus.早期病理诊断:达成国际共识。
Oncology. 2010 Jul;78 Suppl 1:31-5. doi: 10.1159/000315227. Epub 2010 Jul 8.
6
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.磷脂酰肌醇蛋白聚糖-3的表达可将小肝细胞癌与肝硬化、发育异常结节及局灶性结节样增生样结节区分开来。
Am J Surg Pathol. 2006 Nov;30(11):1405-11. doi: 10.1097/01.pas.0000213323.97294.9a.
7
An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.肝癌发生过程中的早期病变:人类肝硬化肝脏及发育异常结节中1p36 - p34区域的杂合性缺失
Hepatology. 2001 Jun;33(6):1415-24. doi: 10.1053/jhep.2001.24751.
8
Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.乙型肝炎病毒相关肝癌发生发育异常结节中hTERT mRNA表达的定量评估
Am J Gastroenterol. 2006 Apr;101(4):831-8. doi: 10.1111/j.1572-0241.2006.00532.x. Epub 2006 Feb 22.
9
Pathomorphological study on small nodular lesions in hepatitis C virus-related cirrhosis.丙型肝炎病毒相关性肝硬化中小结节病变的病理形态学研究
Oncol Rep. 2005 Dec;14(6):1469-74.
10
Histopathology of liver cancers.肝癌的组织病理学
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):39-62. doi: 10.1016/j.bpg.2004.10.007.

引用本文的文献

1
Evaluating the GALAD Score for Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.评估GALAD评分在肝硬化患者中检测肝细胞癌的价值。
J Clin Gastroenterol. 2025 Oct 1;59(9):915-919. doi: 10.1097/MCG.0000000000002097.
2
Nodule-in-nodule architecture of hepatocellular carcinomas: enhancement patterns in the hepatobiliary phase and pathological features.肝癌的结节内结节样结构:肝胆期强化模式和病理特征。
Abdom Radiol (NY). 2024 Nov;49(11):3834-3846. doi: 10.1007/s00261-024-04259-y. Epub 2024 Jun 24.
3
A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
一种用于预测 HCC 患者射频消融治疗后肝内无复发生存的新型列线图。
Br J Radiol. 2024 Mar 28;97(1156):844-849. doi: 10.1093/bjr/tqae038.
4
State-of-the-art review on the correlations between pathological and magnetic resonance features of cirrhotic nodules.肝硬化结节的病理与磁共振特征相关性的最新研究进展综述。
Histol Histopathol. 2022 Dec;37(12):1151-1165. doi: 10.14670/HH-18-487. Epub 2022 Jun 30.
5
Application and Evaluation of a 64-Slice CT Three-Dimensional Fusion Technique in the Determination of the Effective Ablation Margin after Radiofrequency Ablation of Hepatocellular Carcinoma.64 层 CT 三维融合技术在肝癌射频消融后有效消融边界确定中的应用与评估。
Comput Math Methods Med. 2022 Jan 27;2022:6898233. doi: 10.1155/2022/6898233. eCollection 2022.
6
Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients.GNAS自身抗体在肝细胞癌早期检测中的应用:一项结合肝癌患者系列血清验证的大规模样本研究
Biomedicines. 2022 Jan 4;10(1):97. doi: 10.3390/biomedicines10010097.
7
Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis.肝脏疾病严重程度可预测肝硬化中肝发育不良结节的癌变。
Sci Rep. 2021 Oct 25;11(1):20954. doi: 10.1038/s41598-021-00474-5.
8
Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.胃肠道的表观遗传学改变:癌症生物标志物的当前和新兴用途。
Gastroenterology. 2021 Feb;160(3):690-709. doi: 10.1053/j.gastro.2020.09.058. Epub 2020 Dec 3.
9
Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.肝细胞癌的磁共振成像的要点与陷阱。
World J Gastroenterol. 2020 May 7;26(17):2012-2029. doi: 10.3748/wjg.v26.i17.2012.
10
OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer.OTULIN 可以保护肝脏免受细胞死亡、炎症、纤维化和癌症的侵害。
Cell Death Differ. 2020 May;27(5):1457-1474. doi: 10.1038/s41418-020-0532-1. Epub 2020 Mar 30.